Evidence map›Paper›PMID 28722018›Full record

ArticleImmunology and cell biology2017

A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Matthew S Mangan, Carolina R Melo-Silva, Jennii Luu, Catherina H Bird, Aulikki Koskinen, Alexandra Rizzitelli, Monica Prakash, Katrina L Scarff, Arno Müllbacher, Matthias Regner and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Crystallization and crystallographic studies of human serine protease inhibitor (serpin) B9.Acta crystallographica. Section F, Structural biology communications · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. LncRNA SERPINB9P1 expression and polymorphisms are associated with ischemic stroke in a Chinese Han population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. SerpinB1 controls encephalitogenic T helper cells in neuroinflammation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Matthew S ManganDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Carolina R Melo-SilvaDepartment of Emerging Pathogens and Immunity, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia.
Jennii LuuDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Catherina H BirdDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Aulikki KoskinenDepartment of Emerging Pathogens and Immunity, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia.
Alexandra RizzitelliDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Monica PrakashDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Katrina L ScarffDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Arno MüllbacherDepartment of Emerging Pathogens and Immunity, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia.
Matthias RegnerDepartment of Emerging Pathogens and Immunity, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia.
Phillip I BirdDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Australian National University · AUAustralian Regenerative Medicine Institute · AUDiscovery Institute · USMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracellular serpins are proposed to inactivate proteases released from lysosome-related organelles into the host cell interior, preventing cell death. Serpinb9 opposes the immune cytotoxic protease, granzyme B, and in a number of settings protects cells against granzyme B-mediated cell death. Using a knockout mouse line engineered to express green fluorescent protein under the serpbinb9 promoter, we demonstrate that serpinb9 is vital for host survival during Ectromelia virus infection by maintaining both mature natural killer NK) cells, and activated CD8

Indexed as

AnimalsCell DeathCell SurvivalGranzymesHomeostasisHumansIntracellular SpaceKiller Cells, NaturalMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutPoxviridaePoxviridae InfectionsSerpinsGranzymesMembrane ProteinsSerpinb9 protein, mouseSerpins

Identifiers

PMID28722018
OpenAlexW2739415517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.